TE_171
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | MSTC |
---|---|
TE superfamily | MaLR |
TE class | LTR |
Gene | - |
Class | Intergenic |
Coding | Non-coding |
Tumor-specific score | 1.99 |
Counts of samples | TCGA_tumor:135; TCGA_normal:4; GTEx:72 |
TSS | chr1(-):17140154 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_171.11 | - | Intergenic | Non-coding | Non-coding | chr1(-):17134677,17134697,17134793,17136628,17140023,17140155 |
teRNA_171.12 | - | Intergenic | Non-coding | Non-coding | chr1(-):17134623,17134643,17134773,17134935,17135105,17139185,17140023,17140155 |
teRNA_171.13 | - | Intergenic | Non-coding | Non-coding | chr1(-):17134693,17134713,17134773,17136628,17138319,17139185,17140023,17140155 |
teRNA_171.14 | - | Intergenic | Non-coding | Non-coding | chr1(-):17134737,17134757,17134846,17139185,17140023,17140155 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.